From: DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
Description
Group A (N = 238)
Group B (N = 161)
Total
Gender
Male (n)
112
69
181 (45.4%)
Female (n)
126
92
218 (45.4%)
Age (months)
Mean ± SD
19 ± 0.8
20 ± 0.9
20 ± 1.0
Min-max
18–22
19–24
18–24